Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

被引：63

作者：

Furst, D. E.

Breedveld, F. C.

Kalden, J. R.

Smolen, J. S.

Burmester, G. R.

Emery, P.

Keystone, E. C.

Schiff, M. H.

van Riel, P. L. C. M.

Weinblatt, M. E.

Weisman, M. H.

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA

[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands

[3] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med 3, D-8520 Erlangen, Germany

[4] Vienna Gen Hosp, Inst Rheumatol, Clin Internal Med 3, Vienna, Austria

[5] Charite Hosp, Dept Rheumatal & Clin Immunol, Berlin, Germany

[6] Univ Leeds, Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England

[7] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON M5G 1X5, Canada

[8] Denver Arthrit Clin, Denver, CO USA

[9] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[10] Brigham & Womens Hosp, Boston, MA 02115 USA

[11] Cedar Sinai Hosp, Los Angeles, CA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷

关键词：

D O I：

10.1136/ard.2006.061937

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 15

页数：14

共 264 条

[101] Refractory adult onset Still's disease successfully treated with anakinra [J].

Godinho, FMV ;

Santos, MJP ;

da Silva, JC .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (04) :647-648

[102] Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α [J].

Gorman, JD ;

Sack, KE ;

Davis, JC .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1349-1356

[103] Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides -: A followup report of tolerability and efficacy [J].

Gottenberg, JE ;

Merle-Vincent, F ;

Bentaberry, F ;

Allanore, Y ;

Berenbaum, F ;

Fautrel, B ;

Combe, B ;

Durbach, A ;

Sibilia, J ;

Dougados, M ;

Mariette, X .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :2019-2024

[104]

GOTTLIEB AB, 2004, 20 WORLD C DERM 14 1

[105]

Goupille P, 1996, J RHEUMATOL, V23, P791

[106]

Griffiths B, 2005, ARTHRITIS RHEUM-US, V52, pS193

[107] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report [J].

Gulli, S ;

Arrigo, C ;

Bocchino, L ;

Morgante, L ;

Sangari, D ;

Castagna, I ;

Bagnato, GF .

BMC MUSCULOSKELETAL DISORDERS, 2003, 4 (1) :1-4

[108] Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial [J].

Haibel, H ;

Rudwaleit, M ;

Brandt, HC ;

Grozdanovic, Z ;

Listing, J ;

Kupper, H ;

Braun, J ;

Sieper, J .

ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :678-681

[109] Open label trial of anakinra in active ankylosing spondylitis over 24 weeks [J].

Haibel, H ;

Rudwaleit, M ;

Listing, J ;

Sieper, J .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :296-298

[110]

HAIBEL H, 2005, ADALIMUMAB TREATMENT

← 6 7 8 9 10 11 12 13 14 15 →